Liver-specific deletion of histone deacetylase 3 disrupts metabolic transcriptional networks
Open accessAbstract
Histone deacetylase 3 (Hdac3) is an enzymatic component of transcriptional repression complexes recruited by the nuclear hormone receptors. Inactivation of Hdac3 in cancer cell lines triggered apoptosis, and removal of Hdac3 in the germ line of mice caused embryonic lethality. Therefore, we deleted Hdac3 in the postnatal mouse liver. These mice developed hepatomegaly, which was the result of hepatocyte hypertrophy, and these morphological changes coincided with significant imbalances between carbohydrate and lipid metabolism. Loss of Hdac3 triggered changes in gene expression consistent with inactivation of repression mediated by nuclear hormone receptors. Loss of Hdac3 also increased the levels of Ppar gamma2, and treatment of these mice with a Ppar gamma antagonist partially reversed the lipid accumulation in the liver. In addition, gene expression analysis identified mammalian target of rapamycin signalling as being activated after deletion of Hdac3, and inhibition by rapamycin affected the accumulation of neutral lipids in Hdac3-null livers. Thus, Hdac3 regulates metabolism through multiple signalling pathways in the liver, and deletion of Hdac3 disrupts normal metabolic homeostasis.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Mice with a liver-specific deletion of Hdac3 display increased expression of de novo lipogenesis enzymes due to a constitutively active transcriptional environment, resulting in fatty liver disease and elevated serum cholesterol.
“Mice with a liver-specific deletion of Hdac3 display an increased expression of de novo lipogenesis enzymes due to a constitutively active transcriptional environment, resulting in fatty liver disease and elevated serum cholesterol [178,179].”
From Rett syndrome: a neurological disorder with metabolic components (2018) · cites this paper as [178]
Sqle is a target of HDAC3, and its transcription increases approximately 170-fold in response to Hdac3 liver deletion.
“In support of this, Sqle, the suppressor of RTT-like phenotypes in mice, is a target of HDAC3, and its transcription increases approximately 170-fold in response to Hdac3 liver deletion [156,178].”
From Rett syndrome: a neurological disorder with metabolic components (2018) · cites this paper as [178]
Promoter regions of lipid/cholesterol homeostasis genes, including Sqle, appear to be targets of HDAC3 in the liver.
“Interestingly, the promoter regions of lipid/cholesterol homeostasis genes, including Sqle, appear to be targets of HDAC3 in the liver55.”
From A suppressor screen in Mecp2 mutant mice implicates cholesterol metabolism in Rett syndrome (2013) · cites this paper as [55]
FLD in 129.Mecp2tm1.1Bird mice is similar to that in a liver-specific knockout of HDAC3.
“FLD in 129.Mecp2tm1.1Bird mice is similar to that in a liver-specific knockout of HDAC355,56.”
From A suppressor screen in Mecp2 mutant mice implicates cholesterol metabolism in Rett syndrome (2013) · cites this paper as [55]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Upstream and downstream of mTOR
Hay, N., & Sonenberg, N. (2004) · Genes & Development · doi:10.1101/gad.1212704 · Cited by 4,181 · see citing works
Lehmann, J. M., Moore, L. B., Smith-Oliver, T. A., Wilkison, W. O., Willson, T. M., & Kliewer, S. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.22.12953 · Cited by 3,626 · see citing works
Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor
Tontonoz, P., Hu, E., & Spiegelman, B. M. (1994) · Cell · doi:10.1016/0092-8674(94)90006-x · Cited by 3,533 · see citing works
Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase
Imai, S.-I., Armstrong, C. M., Kaeberlein, M., & Guarente, L. (2000) · Nature · doi:10.1038/35001622 · Cited by 3,510 · see citing works
Histone deacetylases (HDACs): characterization of the classical HDAC family
RUIJTER, A. J. M. D., GENNIP, A. H. V., CARON, H. N., KEMP, S., & KUILENBURG, A. B. P. V. (2003) · Biochemical Journal · doi:10.1042/bj20021321 · Cited by 3,114 · see citing works
PANTHER: A Library of Protein Families and Subfamilies Indexed by FunctionPreprint
Thomas, P. D., Campbell, M. J., Kejariwal, A., Mi, H., Karlak, B., Daverman, R., Diemer, K., Muruganujan, A., & Narechania, A. (2003) · Genome Research · doi:10.1101/gr.772403 · Cited by 2,912 · see citing works
HDAC6 is a microtubule-associated deacetylase
Hubbert, C., Guardiola, A., Shao, R., Kawaguchi, Y., Ito, A., Nixon, A., Yoshida, M., Wang, X.-F., & Yao, T.-P. (2002) · Nature · doi:10.1038/417455a · Cited by 2,403 · see citing works
Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive
Jacinto, E., Loewith, R., Schmidt, A., Lin, S., Rüegg, M. A., Hall, A., & Hall, M. N. (2004) · Nature Cell Biology · doi:10.1038/ncb1183 · Cited by 2,097 · see citing works
Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-γ
Picard, F., Kurtev, M. V., Chung, N., Topark‐Ngarm, A., Senawong, T., de Oliveira, R. M., Leid, M. E., McBurney, M. W., & Guarente, L. (2004) · Nature · doi:10.1038/nature02583 · Cited by 1,943 · see citing works
Inducible Gene Targeting in Mice
Kühn, R., Schwenk, F., Aguet, M., & Rajewsky, K. (1995) · Science · doi:10.1126/science.7660125 · Cited by 1,915 · see citing works
Loewith, R., Jacinto, E., Wullschleger, S., Lorberg, A., Crespo, J. L., Bonenfant, D., Oppliger, W., Jenoe, P., & Hall, M. N. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00636-6 · Cited by 1,886 · see citing works
Postic, C., Shiota, M., Niswender, K. D., Jetton, T. L., Chen, Y., Moates, J. M., Shelton, K. D., Lindner, J., Cherrington, A. D., & Magnuson, M. A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.1.305 · Cited by 1,302 · see citing works
Fingar, D. C., & Blenis, J. (2004) · Oncogene · doi:10.1038/sj.onc.1207542 · Cited by 1,250 · see citing works
Role of the histone deacetylase complex in acute promyelocytic leukaemia
Lin, R. J., Nagy, L., Inoue, S., Shao, W., Miller, W. H., & Evans, R. M. (1998) · Nature · doi:10.1038/35895 · Cited by 1,060 · see citing works
Grignani, F., Matteis, S. D., Nervi, C., Tomassoni, L., Gelmetti, V., Cioce, M., Fanelli, M., Ruthardt, M., Ferrara, F. F., Zamir, I., et al. (1998) · Nature · doi:10.1038/35901 · Cited by 1,004 · see citing works
Deacetylation of p53 modulates its effect on cell growth and apoptosis
Luo, J., Su, F., Chen, D., Shiloh, A., & Gu, W. J. (2000) · Nature · doi:10.1038/35042612 · Cited by 818 · see citing works
Essential function of histone deacetylase 1 in proliferation control and CDK inhibitor repression
Lagger, G., O'Carroll, D., Rembold, M., Khier, H., Tischler, J., Weitzer, G., Schuettengruber, B., Hauser, C., Brunmeir, R., Jenuwein, T., et al. (2002) · The EMBO Journal · doi:10.1093/emboj/21.11.2672 · Cited by 760 · see citing works
Fischle, W., Dequiedt, F., Hendzel, M. J., Guenther, M. G., Lazar, M. A., Voelter, W., & Verdin, E. (2002) · Molecular Cell · doi:10.1016/s1097-2765(01)00429-4 · Cited by 754 · see citing works
Ashburner, B. P., Westerheide, S. D., & Baldwin, A. S. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.20.7065-7077.2001 · Cited by 732 · see citing works
Shyng, S., Lehmann, S., Moulder, K. L., & Harris, D. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.50.30221 · Cited by 704 · see citing works
HDACs, histone deacetylation and gene transcription: from molecular biology to cancer therapeutics
Gallinari, P., Marco, S. D., Jones, P., Pallaoro, M., & Steinkühler, C. (2007) · Cell Research · doi:10.1038/sj.cr.7310149 · Cited by 678 · see citing works
Both corepressor proteins SMRT and N‐CoR exist in large protein complexes containing HDAC3
Li, J., Wang, J., Wang, J., Nawaz, Z., Liu, J. M., Qin, J., & Wong, J. (2000) · The EMBO Journal · doi:10.1093/emboj/19.16.4342 · Cited by 629 · see citing works
Yu, S., Matsusue, K., Kashireddy, P. V., Cao, W.-Q., Yeldandi, V., Yeldandi, A. V., Rao, M. S., Gonzalez, F. J., & Reddy, J. K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m210062200 · Cited by 621 · see citing works
The SMRT and N-CoR Corepressors Are Activating Cofactors for Histone Deacetylase 3
Guenther, M. G., Barak, O., & Lazar, M. A. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.18.6091-6101.2001 · Cited by 611 · see citing works
Unraveling the hidden catalytic activity of vertebrate class IIa histone deacetylases
Lahm, A., Paolini, C., Pallaoro, M., Nardi, M. C., Jones, P., Neddermann, P., Sambucini, S., Bottomley, M. J., Lo Surdo, P., Carfı́, A., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706487104 · Cited by 566 · see citing works
He, L.-Z., Guidez, F., Tribioli, C., Peruzzi, D., Ruthardt, M., Zelent, A., & Pandolfi, P. P. (1998) · Nature Genetics · doi:10.1038/ng0298-126 · Cited by 555 · see citing works
Histone deacetylase inhibitors as new cancer drugs
Marks, P. A., Richon, V. M., Breslow, R., & Rifkind, R. A. (2001) · Current Opinion in Oncology · doi:10.1097/00001622-200111000-00010 · Cited by 531 · see citing works
Hdac2 regulates the cardiac hypertrophic response by modulating Gsk3β activity
Trivedi, C. M., Luo, Y., Yin, Z., Zhang, M., Zhu, W., Wang, T., Floß, T., Göttlicher, M., Ruíz, P., Wurst, W., et al. (2007) · Nature Medicine · doi:10.1038/nm1552 · Cited by 469 · see citing works
Yoon, H., Chan, D. W., Huang, Z., Li, J., Fondell, J. D., Qin, J., & Wong, J. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg120 · Cited by 444 · see citing works
Histone Deacetylases Specifically Down-regulate p53-dependent Gene Activation
Juan, L.-J., Shia, W.-J., Chen, M.-H., Yang, W., Seto, E., Lin, Y.-S., & Wu, C.-W. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000202200 · Cited by 415 · see citing works
Zhu, Y., Alvares, K., Huang, Q. M., Rao, M. S. R., & Reddy, J. K. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)74184-2 · Cited by 374 · see citing works
Mi, H., Guo, N., Kejariwal, A., & Thomas, P. D. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl869 · Cited by 372 · see citing works
Bhaskara, S., Chyla, B., Amann, J. M., Knutson, S. K., Cortez, D., Sun, Z., & Hiebert, S. W. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.02.030 · Cited by 369 · see citing works
Self-citationRen, D., Collingwood, T. N., Rebar, E. J., Wolffe, A. P., & Camp, H. S. (2002) · Genes & Development · doi:10.1101/gad.953802 · Cited by 362 · see citing works
Amann, J. M., Nip, J., Strom, D. K., Lutterbach, B. A., Harada, H., Lenny, N. T., Downing, J. R., Meyers, S., & Hiebert, S. W. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.19.6470-6483.2001 · Cited by 336 · see citing works
Self-citationCorepressors selectively control the transcriptional activity of PPARγ in adipocytesPreprint
Guan, H.-P., Ishizuka, T., Chui, P. C., Lehrke, M., & Lazar, M. A. (2005) · Genes & Development · doi:10.1101/gad.1263305 · Cited by 293 · see citing works
Guidez, F., Ivins, S. M., Zhu, J., Söderström, M., Waxman, S., & Zelent, A. (1998) · Blood · doi:10.1182/blood.v91.8.2634.2634_2634_2642 · Cited by 292 · see citing works
Werman, A., Hollenberg, A. N., Solanes, G., Bjørbæk, C., Vidal‐Puig, A., & Flier, J. S. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.32.20230 · Cited by 282 · see citing works
Negative and Positive Regulation of Gene Expression by Mouse Histone Deacetylase 1
Zupkovitz, G., Tischler, J., Posch, M., Sadzak, I., Ramsauer, K., Egger, G., Grausenburger, R., Schweifer, N., Chiocca, S., Decker, T., et al. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.01220-06 · Cited by 262 · see citing works
The Retinoblastoma-Histone Deacetylase 3 Complex Inhibits PPARγ and Adipocyte Differentiation
Lluis Fajas, A., Egler, V., Reiter, R. J., Hansen, J. B., Kristiansen, K., Debril, M.-B., Miard, S., & Auwerx, J. H. (2002) · Developmental Cell · doi:10.1016/s1534-5807(02)00360-x · Cited by 258 · see citing works
Alcalay, M., Zangrilli, D., Pandolfi, P. P., Longo, L., Mencarelli, A., Giacomucci, A., Rocchi, M., Biondi, A., Rambaldi, A., & Coco, F. L. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.5.1977 · Cited by 243 · see citing works
Role of Class I and Class II histone deacetylases in carcinoma cells using siRNA
Glaser, K. B., Li, J., Staver, M. J., Wei, R.-Q., Albert, D. H., & Davidsen, S. K. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.09.043 · Cited by 220 · see citing works
Mechanisms of Disease: pathogenesis of nonalcoholic fatty liver disease
Sanyal, A. J. (2005) · Nature Clinical Practice Gastroenterology & Hepatology · doi:10.1038/ncpgasthep0084 · Cited by 216 · see citing works
Histone Deacetylase 3 Interacts with and Deacetylates Myocyte Enhancer Factor 2
Grégoire, S., Xiao, L., Nie, J., Zhang, X., Xu, M., Li, J., Wong, J., Seto, E., & Yang, X.-J. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00882-06 · Cited by 203 · see citing works
A novel histone deacetylase pathway regulates mitosis by modulating Aurora B kinase activityPreprint
Li, Y., Kao, G. D., Garcia, B. A., Shabanowitz, J., Hunt, D. F., Qin, J., Phelan, C. A., & Lazar, M. A. (2006) · Genes & Development · doi:10.1101/gad.1455006 · Cited by 175 · see citing works
Ono, H., Shimano, H., Katagiri, H., Yahagi, N., Sakoda, H., Onishi, Y., Anai, M., Ogihara, T., Fujishiro, M., Viana, A. Y. I., et al. (2003) · Diabetes · doi:10.2337/diabetes.52.12.2905 · Cited by 168 · see citing works
Both TEL and AML-1 Contribute Repression Domains to the t(12;21) Fusion Protein
Fenrick, R., Amann, J. M., Lutterbach, B., Wang, L., Westendorf, J. J., Downing, J. R., & Hiebert, S. W. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.10.6566 · Cited by 162 · see citing works
The mammalian target of rapamycin regulates lipid metabolism in primary cultures of rat hepatocytes
Brown, N. F., Stefanović-Račić, M., SIPULA, I. J., & Perdomo, G. (2007) · Metabolism · doi:10.1016/j.metabol.2007.06.016 · Cited by 152 · see citing works
Zhang, Y., Hernández‐Ono, A., Siri, P. W., Weisberg, S. P., Conlon, D., Graham, M. J., Crooke, R. M., Huang, L., & Ginsberg, H. N. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m604709200 · Cited by 151 · see citing works
Chakrabarti, S. R., & Nucifora, G. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1605 · Cited by 149 · see citing works
Dual roles for cholesterol in mammalian cells
Xu, F., Rychnovsky, S. D., Belani, J. D., Hobbs, H. H., Cohen, J. C., & Rawson, R. B. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503590102 · Cited by 140 · see citing works
Guidez, F., Petrie, K. R., Ford, A. M., Lu, H., Bennett, C. A., MacGregor, A., Hannemann, J., Ito, Y., Ghysdael, J., Greaves, M. F., et al. (2000) · Blood · doi:10.1182/blood.v96.7.2557 · Cited by 134 · see citing works
Santini, V., Gozzini, A., & Ferrari, G. (2007) · Current Drug Metabolism · doi:10.2174/138920007780655397 · Cited by 131 · see citing works
Haga, S., Ogawa, W., Inoue, H., Terui, K., Ogino, T., Igarashi, R., Takeda, K., Akira, S., Enosawa, S., Furukawa, H., et al. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.03.027 · Cited by 108 · see citing works
Fenrick, R., Wang, L., Nip, J., Amann, J. M., Rooney, R. J., Walker‐Daniels, J., Crawford, H. C., Hulboy, D. L., Kinch, M. S., Matrisian, L. M., et al. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.16.5828-5839.2000 · Cited by 106 · see citing works
Self-citationDebeljak, N., Fink, M., & Rozman, D. (2003) · Archives of Biochemistry and Biophysics · doi:10.1016/s0003-9861(02)00418-6 · Cited by 103 · see citing works
The Sir proteins of Saccharomyces cerevisiae: mediators of transcriptional silencing and much more
Gartenberg, M. R. (2000) · Current Opinion in Microbiology · doi:10.1016/s1369-5274(00)00064-3 · Cited by 101 · see citing works
TEL contacts multiple co-repressors and specifically associates with histone deacetylase-3
Wang, L., & Hiebert, S. W. (2001) · Oncogene · doi:10.1038/sj.onc.1204479 · Cited by 101 · see citing works
Self-citationTakami, Y., & Nakayama, T. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m908066199 · Cited by 98 · see citing works
Hernández, R., Teruel, T., & Lorenzo, M. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02353-5 · Cited by 93 · see citing works
Mordier, S. B., & Iynedjian, P. B. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.08.004 · Cited by 82 · see citing works
Hartman, H. B., Yu, J., Alenghat, T., Ishizuka, T., & Lazar, M. A. (2005) · EMBO Reports · doi:10.1038/sj.embor.7400391 · Cited by 82 · see citing works
Identification of a second human acetyl-CoA carboxylase gene
Widmer, J., FASSIHI, K. S., SCHLICHTER, S. C., WHEELER, K. S., Crute, B. E., Nicole, K. I. N. G., Nutile‐McMenemy, N., Noll, W. W., Daniel, S., Ha, J., et al. (1996) · Biochemical Journal · doi:10.1042/bj3160915 · Cited by 75 · see citing works
Thermogenic and metabolic antiobesity drugs: rationale and opportunities
Clapham, J. C., & Arch, J. R. S. (2007) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2006.00608.x · Cited by 60 · see citing works
Papeleu, P., Loyer, P., Vanhaecke, T., Elaut, G., Geerts, A. E., Guguen‐Guillouzo, C., & Rogiers, V. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00288-5 · Cited by 58 · see citing works
Regulation of SV40 large T-antigen stability by reversible acetylation
Shimazu, T., Komatsu, Y., Nakayama, K. I., Fukazawa, H., Horinouchi, S., & Yoshida, M. (2006) · Oncogene · doi:10.1038/sj.onc.1209731 · Cited by 49 · see citing works
HDACs, histone deacetylation and gene transcription： from molecular biology to cancer therapeutics
Paola, Gallinari, Di, Marco, M. D., Phillip, Jones, Michèle, Pallaoro, Christian, C., & Steinkühler (2007) · Acta Scientiarum Naturalium Universitatis Sunyatseni · Cited by 35 · see citing works
Niwa‐Kawakita, M., Abramowski, V., Kalamarides, M., Thomas, G. D., & Giovannini, M. (2000) · genesis · doi:10.1002/(sici)1526-968x(200002)26:2 · Cited by 22 · see citing works
Physiological relevance of apolipoprotein E recycling: studies in primary mouse hepatocytes
Zhu, M.-Y., Hasty, A. H., Harris, C. M., Linton, M. F., Fazio, S., & Swift, L. L. (2005) · Metabolism · doi:10.1016/j.metabol.2005.04.019 · Cited by 12 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Haberland, M., Montgomery, R. L., & Olson, E. N. (2008) · Nature Reviews Genetics · doi:10.1038/nrg2485 · Cited by 2,541 · see citing works
Energy Metabolism in the Liver
Rui, L. (2014) · Comprehensive physiology · doi:10.1002/cphy.c130024 · Cited by 2,258 · see citing works
HDAC family: What are the cancer relevant targets?
Witt, O., Deubzer, H. E., Milde, T., & Oehme, I. (2009) · Cancer Letters · doi:10.1016/j.canlet.2008.08.016 · Cited by 1,069 · see citing works
Ketone bodies as signaling metabolites
Newman, J. C., & Verdin, E. (2014) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2013.09.002 · Cited by 966 · see citing works
β-Hydroxybutyrate: A Signaling Metabolite
Newman, J. C., & Verdin, E. (2017) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-071816-064916 · Cited by 872 · see citing works
“HDAC3 regulates expression of gluconeogenic genes (86), and HDAC3 knockout mice have reduced fasting glucose and insulin levels (8, 26, 63).”
The world of protein acetylation
Drazic, A., Myklebust, L. M., Ree, R., & Arnesen, T. (2016) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2016.06.007 · Cited by 799 · see citing works
A circadian rhythm orchestrated by histone deacetylase 3 controls hepatic lipid metabolism
Feng, D., Liu, T., Sun, Z., Bugge, A., Mullican, S. E., Alenghat, T., Liu, X. S., & Lazar, M. A. (2011) · Science · doi:10.1126/science.1198125 · Cited by 701 · see citing works
Deconstructing repression: evolving models of co-repressor action
Perissi, V., Jepsen, K., Glass, C. K., & Rosenfeld, M. G. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2736 · Cited by 532 · see citing works
Energy Metabolism in the Liver
Rui, L. (2014) · Comprehensive physiology · doi:10.1002/j.2040-4603.2014.tb00548.x · Cited by 382 · see citing works
Bhaskara, S., Chyla, B., Amann, J. M., Knutson, S. K., Cortez, D., Sun, Z., & Hiebert, S. W. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.02.030 · Cited by 369 · see citing works
Self-citationMaintenance of cardiac energy metabolism by histone deacetylase 3 in mice
Montgomery, R. L., Potthoff, M. J., Haberland, M., Qi, X., Matsuzaki, S., Humphries, K. M., Richardson, J. A., Bassel‐Duby, R., & Olson, E. N. (2008) · Journal of Clinical Investigation · doi:10.1172/jci35847 · Cited by 363 · see citing works
Hdac3 is essential for the maintenance of chromatin structure and genome stability
Bhaskara, S., Knutson, S. K., Jiang, G., Chandrasekharan, M. B., Wilson, A. J., Zheng, S., Yenamandra, A., Locke, K., Yuan, J.-L., Bonine-Summers, A. R., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.10.022 · Cited by 353 · see citing works
Self-citationHepatic Hdac3 promotes gluconeogenesis by repressing lipid synthesis and sequestration
Sun, Z., Miller, R. A., Patel, R. T., Chen, J., Dhir, R., Wang, H., Zhang, D., Graham, M. J., Unterman, T. G., Shulman, G. I., et al. (2012) · Nature Medicine · doi:10.1038/nm.2744 · Cited by 335 · see citing works
Protein acetylation in metabolism – metabolites and cofactors
Menzies, K. J., Zhang, H., Katsyuba, E., & Auwerx, J. (2016) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2015.181 · Cited by 331 · see citing works
β-hydroxybutyrate: Much more than a metabolite
Newman, J. C., & Verdin, E. M. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2014.08.009 · Cited by 334 · see citing works
Keating, S. T., & El‐Osta, A. (2015) · Circulation Research · doi:10.1161/circresaha.116.303936 · Cited by 315 · see citing works
Histone deacetylase 3 is an epigenomic brake in macrophage alternative activation
Mullican, S. E., Gaddis, C. A., Alenghat, T., Nair, M. G., Giacomin, P. R., Everett, L. J., Feng, D., Steger, D. J., Schug, J., Artis, D., et al. (2011) · Genes & Development · doi:10.1101/gad.175950.111 · Cited by 314 · see citing works
Histone Deacetylases and Mechanisms of Regulation of Gene Expression
Chen, H. P., Zhao, Y., & Zhao, T. C. (2015) · Critical Reviews™ in Oncogenesis · doi:10.1615/critrevoncog.2015012997 · Cited by 308 · see citing works
Emerging roles of the corepressors NCoR1 and SMRT in homeostasis
Mottis, A., Mouchiroud, L., & Auwerx, J. (2013) · Genes & Development · doi:10.1101/gad.214023.113 · Cited by 297 · see citing works
Nuclear receptor corepressor and histone deacetylase 3 govern circadian metabolic physiology
Alenghat, T., Meyers, K. C., Mullican, S. E., Leitner, K., Adeniji‐Adele, A., Avila, J. L., Bućan, M., Ahima, R. S., Kaestner, K. H., & Lazar, M. A. (2008) · Nature · doi:10.1038/nature07541 · Cited by 293 · see citing works
Interplay between HDAC3 and WDR5 Is Essential for Hypoxia-Induced Epithelial-Mesenchymal Transition
Wu, M.-Z., Tsai, Y., Yang, M., Huang, C.-H., Chang, S., Chang, C., Teng, S., & Wu, K.-J. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.07.012 · Cited by 273 · see citing works
Essential Role for miR-196a in Brown Adipogenesis of White Fat Progenitor Cells
Mori, M., Nakagami, H., Rodriguez-Araujo, G., Nimura, K., & Kaneda, Y. (2012) · PLoS Biology · doi:10.1371/journal.pbio.1001314 · Cited by 243 · see citing works
Sun, Z., Feng, D., Fang, B., Mullican, S. E., You, S.-H., Lim, H., Everett, L. J., Nabel, C. S., Li, Y., Selvakumaran, V., et al. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.10.022 · Cited by 247 · see citing works
Insights into the activation mechanism of class I HDAC complexes by inositol phosphates
Watson, P. J., Millard, C. J., Riley, A. M., Robertson, N. S., Wright, L. C., Godage, H. Y., Cowley, S. M., Jamieson, A. G., Potter, B. V. L., & Schwabe, J. W. R. (2016) · Nature Communications · doi:10.1038/ncomms11262 · Cited by 244 · see citing works
Galmozzi, A., Mitro, N., Ferrari, A., Gers, E., Gilardi, F., Godio, C., Cermenati, G., Gualerzi, A., Donetti, E., Rotili, D., et al. (2012) · Diabetes · doi:10.2337/db12-0548 · Cited by 236 · see citing works
A suppressor screen in Mecp2 mutant mice implicates cholesterol metabolism in Rett syndrome
Buchovecky, C. M., Turley, S. D., Brown, H. M., Kyle, S. M., McDonald, J. G., Liu, B., Pieper, A. A., Huang, W., Katz, D. M., Russell, D. W., et al. (2013) · Nature Genetics · doi:10.1038/ng.2714 · Cited by 234 · see citing works
Overlapping functions of Hdac1 and Hdac2 in cell cycle regulation and haematopoiesis
Wilting, R. H., Yanover, E., Heideman, M. R., Jacobs, H., Horner, J. W., van der Torre, J., DePinho, R. A., & Dannenberg, J. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.136 · Cited by 229 · see citing works
Epigenetic control of skull morphogenesis by histone deacetylase 8Preprint
Haberland, M., Mokalled, M. H., Montgomery, R. L., & Olson, E. N. (2009) · Genes & Development · doi:10.1101/gad.1809209 · Cited by 223 · see citing works
Rett syndrome: a neurological disorder with metabolic components
Kyle, S. M., Vashi, N., & Justice, M. J. (2018) · Open Biology · doi:10.1098/rsob.170216 · Cited by 213 · see citing works
Integrative regulation of physiology by histone deacetylase 3
Emmett, M. J., & Lazar, M. A. (2019) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-018-0076-0 · Cited by 202 · see citing works
Nuclear receptor co-repressors are required for the histone-deacetylase activity of HDAC3 in vivo
You, S.-H., Lim, H., Sun, Z., Broache, M., Won, K., & Lazar, M. A. (2013) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2476 · Cited by 200 · see citing works
Multiple roles of class I HDACs in proliferation, differentiation, and development
Reichert, N., Choukrallah, M.-A., & Matthias, P. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-0921-9 · Cited by 194 · see citing works
Milde, T., Oehme, I., Korshunov, A., Kopp‐Schneider, A., Remke, M., Northcott, P. A., Deubzer, H. E., Lodrini, M., Taylor, M. D., von Deimling, A., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0395 · Cited by 192 · see citing works
Synergistic Enhancement of Cancer Therapy Using HDAC Inhibitors: Opportunity for Clinical Trials
Hontecillas‐Prieto, L., Flores-Campos, R., Silver, A. R., de Álava, E., Hajji, N., & García-Domínguez, D. J. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.578011 · Cited by 182 · see citing works
Hyaluronic Acid Promotes Angiogenesis by Inducing RHAMM-TGFβ Receptor Interaction via CD44-PKCδ
Park, D., Kim, Y., Kim, H., Kim, K., Lee, Y., Choe, J., Hahn, J.-H., Lee, H., Jeon, J., Choi, C., et al. (2012) · Molecules and Cells · doi:10.1007/s10059-012-2294-1 · Cited by 178 · see citing works
Zampetaki, A., Zeng, L., Margariti, A., Xiao, Q., Li, H., Zhang, Z., Pepe, A. E., Wang, G., Habi, O., DEFALCO, E., et al. (2009) · Circulation · doi:10.1161/circulationaha.109.890491 · Cited by 173 · see citing works
Li, Z., & Zhu, W. (2014) · International Journal of Biological Sciences · doi:10.7150/ijbs.9067 · Cited by 160 · see citing works
Histone Deacetylase Inhibitors for Treating a Spectrum of Diseases Not Related to Cancer
Dinarello, C. A., Fossati, G., & Mascagni, P. (2011) · Molecular Medicine · doi:10.2119/molmed.2011.00116 · Cited by 160 · see citing works
Chang, X., Yan, H., Jing, F., Jiang, M., Zhu, H., Lu, D., & Gao, X. (2010) · Journal of Lipid Research · doi:10.1194/jlr.m001958 · Cited by 157 · see citing works
Regulating the Regulators: The Post‐Translational Code of Class I HDAC1 and HDAC2
Segré, C. V., & Chiocca, S. (2010) · BioMed Research International · doi:10.1155/2011/690848 · Cited by 154 · see citing works
The nuclear corepressor, NCoR, regulates thyroid hormone action in vivo
Astapova, I. I., Lee, L. J., Morales, C., Tauber, S., Bilban, M., & Hollenberg, A. N. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804604105 · Cited by 149 · see citing works
Lu, X., Cao, X., Zhu, Y., Wu, Z., Zhuang, X., Shao, M., Xu, Q., Zhou, Y., Ji, H., Lu, Q.-R., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0428-x · Cited by 146 · see citing works
PPARγ contributes to PKM2 and HK2 expression in fatty liver
Panasyuk, G., Espeillac, C., Chauvin, C., Pradelli, L. A., Horie, Y., Suzuki, A., Annicotte, J., Lluis Fajas, A., Foretz, M., Verdeguer, F., et al. (2012) · Nature Communications · doi:10.1038/ncomms1667 · Cited by 140 · see citing works
Regulation of Steatohepatitis and PPARγ Signaling by Distinct AP-1 Dimers
Hasenfuss, S. C., Bakiri, L., Thomsen, M. K., Williams, E. G., Auwerx, J. H., & Wagner, E. F. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2013.11.018 · Cited by 140 · see citing works
Sos, B. C., Harris, C. A., Nordstrom, S. M., Tran, J. L., Balázs, M., Caplazi, P., Febbraio, M., Applegate, M. A. B., Wagner, K., & Weiss, E. J. (2011) · Journal of Clinical Investigation · doi:10.1172/jci42894 · Cited by 135 · see citing works
Histone Deacetylase Inhibitors in Cell Pluripotency, Differentiation, and Reprogramming
Kretsovali, A., Hadjimichael, C., & Charmpilas, N. (2012) · Stem Cells International · doi:10.1155/2012/184154 · Cited by 126 · see citing works
Histone deacetylase inhibitors in cancer therapy
Lee, M.-J., Kim, Y. S., Kummar, S., Giaccone, G., & Trepel, J. B. (2008) · Current Opinion in Oncology · doi:10.1097/cco.0b013e3283127095 · Cited by 125 · see citing works
The coactivator role of histone deacetylase 3 in IL-1-signaling involves deacetylation of p65 NF-κB
Ziesché, E., Kettner-Buhrow, D., Weber, A., Wittwer, T., Jurida, L., Meier‐Soelch, J., Müller, H., Newel, D., Kronich, P., Schneider, H., et al. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks916 · Cited by 123 · see citing works
Self-citationHDAC3 and the molecular brake pad hypothesis
McQuown, S. C., & Wood, M. A. (2011) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2011.04.005 · Cited by 122 · see citing works
Programming and regulation of metabolic homeostasis by HDAC11
Sun, L., Marin de Evsikova, C., Bian, K., Achille, A., Telles, E., Pei, H., & Seto, E. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2018.06.025 · Cited by 125 · see citing works
Trivedi, C. M., Lu, M. M., Wang, Q., & Epstein, J. A. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m803686200 · Cited by 119 · see citing works
Redundant Control of Adipogenesis by Histone Deacetylases 1 and 2
Haberland, M., Carrer, M., Mokalled, M. H., Montgomery, R. L., & Olson, E. N. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.081679 · Cited by 120 · see citing works
López‐Soto, A., Folgueras, A. R., Seto, E., & Gonzalez, S. R. (2009) · Oncogene · doi:10.1038/onc.2009.117 · Cited by 118 · see citing works
Lü, X., Fong, K.-W., Gritsina, G., Wang, F., Baca, S. C., Brea, L. T., Berchuck, J. E., Spisák, S., Ross, J., Morrissey, C. M., et al. (2022) · Nature Genetics · doi:10.1038/s41588-022-01045-8 · Cited by 114 · see citing works
Alphonse, P. A. S., & Jones, P. J. H. (2015) · Lipids · doi:10.1007/s11745-015-4096-7 · Cited by 116 · see citing works
Histone deacetylases in skeletal development and bone mass maintenance
McGee‐Lawrence, M. E., & Westendorf, J. J. (2010) · Gene · doi:10.1016/j.gene.2010.12.003 · Cited by 112 · see citing works
Squalene monooxygenase: a journey to the heart of cholesterol synthesis
Chua, N. K., Coates, H. W., & Brown, A. J. (2020) · Progress in Lipid Research · doi:10.1016/j.plipres.2020.101033 · Cited by 110 · see citing works
Razidlo, D. F., Whitney, T. J., Casper, M. E., McGee‐Lawrence, M. E., Stensgard, B. A., Li, X., Secreto, F. J., Knutson, S. K., Hiebert, S. W., & Westendorf, J. J. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011492 · Cited by 111 · see citing works
Self-citationTranscriptional Coregulators: Fine-Tuning Metabolism
Mouchiroud, L., Eichner, L. J., Shaw, R. J., & Auwerx, J. H. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.03.027 · Cited by 111 · see citing works
Genetic dissection of histone deacetylase requirement in tumor cells
Haberland, M., Johnson, A., Mokalled, M. H., Montgomery, R. L., & Olson, E. N. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903139106 · Cited by 110 · see citing works
Mechanisms of Resistance to Histone Deacetylase Inhibitors
Lee, J., Choy, M. L., & Marks, P. A. (2012) · Advances in cancer research · doi:10.1016/b978-0-12-394387-3.00002-1 · Cited by 108 · see citing works
FOXP3+ regulatory T cell development and function require histone/protein deacetylase 3
Wang, L., Liu, Y., Han, R., Beier, U. H., Bhatti, T. R., Akimova, T., Greene, M. I., Hiebert, S. W., & Hancock, W. W. (2015) · Journal of Clinical Investigation · doi:10.1172/jci77088 · Cited by 103 · see citing works
Self-citationInhibition of Histone Deacetylase 3 Causes Replication Stress in Cutaneous T Cell Lymphoma
Wells, C. E., Bhaskara, S., Stengel, K. R., Zhao, Y., Sirbu, B. M., Chagot, B., Cortez, D., Khabele, D., Chazin, W., Cooper, A. C., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068915 · Cited by 101 · see citing works
Self-citationMetabolic reprogramming by class I and II histone deacetylases
Mihaylova, M. M., & Shaw, R. J. (2012) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2012.09.003 · Cited by 95 · see citing works
HDAC3 Deficiency Promotes Liver Cancer through a Defect in H3K9ac/H3K9me3 Transition
Ji, H., Zhou, Y., Zhuang, X., Zhu, Y., Wu, Z., Lu, Y., Li, S., Zeng, Y., Lu, Q. R., Huo, Y., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-3767 · Cited by 92 · see citing works
Bradley, E. W., Shull, L. C., & Westendorf, J. J. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.423723 · Cited by 91 · see citing works
HDAC3 is essential for DNA replication in hematopoietic progenitor cells
Summers, A. R., Fischer, M. A., Stengel, K. R., Zhao, Y., Kaiser, J. F., Wells, C. E., Hunt, A., Bhaskara, S., Luzwick, J. W., Sampathi, S., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci60806 · Cited by 87 · see citing works
Self-citationHDAC3 is a molecular brake of the metabolic switch supporting white adipose tissue browning
Ferrari, A., Longo, R., Fiorino, E., Silva, R., Mitro, N., Cermenati, G., Gilardi, F., Desvergne, B., Andolfo, A., Magagnotti, C., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00182-7 · Cited by 87 · see citing works
Self-citationSelective Inhibition of HDAC1 and HDAC2 as a Potential Therapeutic Option for B-ALL
Stubbs, M. C., Kim, W., Bariteau, M. A., Davis, T. N., Vempati, S., Minehart, J., Witkin, M., Qi, J., Krivtsov, A., Bradner, J., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-1290 · Cited by 71 · see citing works
MeCP2 co-ordinates liver lipid metabolism with the NCoR1/HDAC3 corepressor complex
Kyle, S. M., Saha, P. K., Brown, H. M., Chan, L. C., & Justice, M. J. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw156 · Cited by 84 · see citing works
Changes in nucleosome occupancy associated with metabolic alterations in aged mammalian liver
Bochkis, I. M., Przybylski, D., Chen, J., & Regev, A. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.09.048 · Cited by 78 · see citing works
Nuclear receptor corepressor complexes in cancer: mechanism, function and regulation.
Wong, M., Guo, C. H., & Zhang, J. (2014) · PubMed Central · Cited by 79 · see citing works
Pharmacological intervention of histone deacetylase enzymes in the neurodegenerative disorders
Gupta, R. V., Ambasta, R. K., & Kumar, P. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117278 · Cited by 79 · see citing works
Complex neuroprotective and neurotoxic effects of histone deacetylases
Thomas, E. A., & D’Mello, S. R. (2018) · Journal of Neurochemistry · doi:10.1111/jnc.14309 · Cited by 75 · see citing works
Eichner, L. J., Curtis, S. D., Brun, S. N., McGuire, C. K., Gushterova, I., Baumgart, J. T., Trefts, E., Ross, D. S., Rymoff, T. J., & Shaw, R. J. (2023) · Science Advances · doi:10.1126/sciadv.add3243 · Cited by 76 · see citing works
Zhou, Y., Peng, J., & Jiang, S. (2014) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2014.03.001 · Cited by 74 · see citing works
Metabolism, HDACs, and HDAC Inhibitors: A Systems Biology Perspective
King, J., Patel, M., & Chandrasekaran, S. (2021) · Metabolites · doi:10.3390/metabo11110792 · Cited by 74 · see citing works
The role of altered protein acetylation in neurodegenerative disease
Kabir, F., Atkinson, R., Cook, A. L., Phipps, A. J., & King, A. E. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.1025473 · Cited by 75 · see citing works
Targeting of HDAC8 and investigational inhibitors in neuroblastoma
Oehme, I., Deubzer, H. E., Lodrini, M., Milde, T., & Witt, O. (2009) · Expert Opinion on Investigational Drugs · doi:10.1517/14728220903241658 · Cited by 75 · see citing works
Nascent RNA sequencing analysis provides insights into enhancer-mediated gene regulation
Wang, J., Zhao, Y., Zhou, X., Hiebert, S. W., Liu, Q., & Shyr, Y. (2018) · BMC Genomics · doi:10.1186/s12864-018-5016-z · Cited by 72 · see citing works
Self-citationSnykers, S., Henkens, T., Rop, E. D., Vinken, M., Fraczek, J., Kock, J. D., Prins, E. D., Geerts, A. E., Rogiers, V., & Vanhaecke, T. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.03.009 · Cited by 74 · see citing works
Histone deacetylase 3 is required for maintenance of bone mass during aging
McGee‐Lawrence, M. E., Bradley, E. W., Dudakovic, A., Carlson, S. W., Ryan, Z. C., Kumar, R., Dadsetan, M., Yaszemski, M. J., Chen, Q., An, K., et al. (2012) · Bone · doi:10.1016/j.bone.2012.10.015 · Cited by 74 · see citing works
Patitucci, C., Couchy, G., Bagattin, A., Cañeque, T., de Reyniès, A., Scoazec, J., Rodriguez, R., Pontoglio, M., Zucman-Rossi, J., Pende, M., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci90327 · Cited by 34 · see citing works
Lawlor, L., & Yang, X. (2019) · International Journal of Oral Science · doi:10.1038/s41368-019-0053-2 · Cited by 75 · see citing works
Targeting oxidative stress in cancer
Lawless, M. W., O'Byrne, K. J., & Gray, S. G. (2010) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2010.526933 · Cited by 72 · see citing works
Improving Insulin Sensitivity With HDAC Inhibitor
Ye, J. (2013) · Diabetes · doi:10.2337/db12-1354 · Cited by 72 · see citing works
Hepatic Osteodystrophy—Molecular Mechanisms Proposed to Favor Its Development
Ehnert, S., Aspera-Werz, R. H., Ruoß, M., Dooley, S., Hengstler, J. G., Nadalin, S., Relja, B., Badke, A., & Nussler, A. K. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20102555 · Cited by 73 · see citing works
An HDAC3-PROX1 corepressor module acts on HNF4α to control hepatic triglycerides
Armour, S. M., Remsberg, J. R., Damle, M., Sidoli, S., Ho, W. Y., Li, Z., Garcia, B. A., & Lazar, M. A. (2017) · Nature Communications · doi:10.1038/s41467-017-00772-5 · Cited by 69 · see citing works
Molecular mechanisms and genome-wide aspects of PPAR subtype specific transactivation
Bugge, A., & Mandrup, S. (2010) · PPAR Research · doi:10.1155/2010/169506 · Cited by 69 · see citing works
Singh, N., Trivedi, C. M., Lu, M., Mullican, S. E., Lazar, M. A., & Epstein, J. A. (2011) · Circulation Research · doi:10.1161/circresaha.111.255067 · Cited by 68 · see citing works
McGee‐Lawrence, M. E., Shull, L. C., Schulze, R. J., Pierce, J. L., McNiven, M. A., Farr, J. N., Khosla, S., Oursler, M. J., & Westendorf, J. J. (2015) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2602 · Cited by 67 · see citing works
Hdac3 is an epigenetic inhibitor of the cytotoxicity program in CD8 T cells
Tay, R. E., Olawoyin, O. M., Cejas, P., Xie, Y., Meyer, C. A., Ito, Y., Weng, Q. Y., Fisher, D. E., Long, H. W., Brown, M. A., et al. (2020) · The Journal of Experimental Medicine · doi:10.1084/jem.20191453 · Cited by 66 · see citing works
Feng, B., Jiao, P., Helou, Y. A., Li, Y., He, Q., Walters, M. S., Salomon, A. R., & Xu, H. (2014) · Diabetes · doi:10.2337/db14-0066 · Cited by 66 · see citing works
Dynamic repression by BCL6 controls the genome-wide liver response to fasting and steatosis
Sommars, M. A., Ramachandran, K., Senagolage, M. D., Futtner, C. R., Germain, D. M., Allred, A. L., Omura, Y., Bederman, I. R., & Barish, G. D. (2019) · eLife · doi:10.7554/elife.43922 · Cited by 66 · see citing works
Adhikari, N., Jha, T., & Ghosh, B. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c01676 · Cited by 74 · see citing works
Epigenetic regulation of cholesterol homeostasis
Meaney, S. (2014) · Frontiers in Genetics · doi:10.3389/fgene.2014.00311 · Cited by 58 · see citing works
Understanding Dietary Intervention-Mediated Epigenetic Modifications in Metabolic Diseases
Asif, S., Morrow, N. M., Mulvihill, E. E., & Kim, K.-H. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.590369 · Cited by 69 · see citing works
Dávalos-Salas, M., Montgomery, M. K., Reehorst, C. M., Nightingale, R., Ng, I., Anderton, H., Al-Obaidi, S. J., Lesmana, A., Scott, C. M., Ioannidis, P., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-13180-8 · Cited by 63 · see citing works
Self-citationYou, S.-H., Liao, X., Weiss, R. E., & Lazar, M. A. (2010) · Molecular Endocrinology · doi:10.1210/me.2009-0501 · Cited by 61 · see citing works
Stengel, K. R., & Hiebert, S. W. (2014) · Antioxidants and Redox Signaling · doi:10.1089/ars.2014.5915 · Cited by 61 · see citing works
Self-citation
- Authors
- Knutson, S. K., Chyla, B. J., Amann, J. M., Bhaskara, S., Huppert, S. S., & Hiebert, S. W.
- Affiliations
- Vanderbilt University (US)
- Corresponding author
- Hiebert, Scott W
- Venue
- The EMBO Journal
- Published
- 2008-03-20
- Volume
- 27
- Issue
- 7
- Pages
- 1017-1028
- ISSN
- 0261-4189 (ISSN-L)
- 1460-2075
- PMC
- PMC2323257
- OpenAlex
- W2149370967
- Cited by
- 271
- References
- 69
- Citations by year
- 2026: 3 · 2025: 10 · 2024: 13 · 2023: 20 · 2022: 7 · 2021: 11 · 2020: 18 · 2019: 14 · 2018: 12 · 2017: 16 · 2016: 20 · 2015: 17 · 2014: 17 · 2013: 23 · 2012: 18
- FWCI
- 7.14
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- The EMBO Journal (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Leukemia and Lymphoma Society
- Vanderbilt University (CA68485)
- Vanderbilt-Ingram Cancer Center (CA68485)
- National Institutes of Health (CA68485, CA009385)
- Vanderbilt Digestive Diseases Research Center, Vanderbilt University Medical Center
- National Cancer Institute (CA68485, R01CA077274, R01CA064140, T32CA009385, T32CA009582, P30CA068485, R01 CA64140, R01-CA77274)
- National Institute of Diabetes and Digestive and Kidney Diseases (5P30DK58404, P30DK058404)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Histone Deacetylase Inhibitors Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Keywords
- HDAC3, liver-specific gene deletion, hepatomegaly, hepatocyte hypertrophy, lipid and carbohydrate metabolism, nuclear receptors, transcriptional repression, PPARγ2, PPARγ antagonist, mTOR signaling, rapamycin, hepatic lipid accumulation, metabolic homeostasis
- MeSH terms
- Histone Deacetylase 3, Acetylation, Animals, Animals, Newborn, Cholesterol, Enzyme Activation, Enzyme Inhibitors, Gene Expression Regulation, Histone Deacetylases, Homeostasis, Hypertrophy, Hypoglycemia, Insulin, Liver, Organ Specificity, Protein Kinases, Gene Deletion, Integrases, Hepatocytes, PPAR gamma, Lipid Metabolism, Mice, Gene Regulatory Networks, TOR Serine-Threonine Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
